Creo Medical Group said the first patients had been successfully treated in the US using its 'Speedboat' medical device. The device enabled the removal of cancerous and pre-cancerous gastrointestinal growths. It used an electrosurgical generator that combined bipolar radiofrequency for precise, localised cutting and microwave for controlled coagulation. Two surgeons from the same hospital were trained in the use of the device over the weekend and successfully used it on the patients this week. Creo said it expected to increase the number of trained clinicians in the US as the roll-out of a company education programme continued. At 1:51pm: (LON:CREO) Creo Medical Group Plc share price was +14p at 226p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.